Search Results - "Patil, Revati"
-
1
Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers
Published in PloS one (17-06-2022)“…Biomarker directed selection of targeted anti-neoplastic agents such as immune checkpoint inhibitors, small molecule inhibitors and monoclonal antibodies form…”
Get full text
Journal Article -
2
Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors
Published in PloS one (08-02-2021)“…We present data on analytical validation of the multigene variant profiling assay (CellDx) to provide actionable indications for selection of targeted and…”
Get full text
Journal Article -
3
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
Published in Clinical case reports (01-11-2021)“…Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely…”
Get full text
Journal Article -
4
Abstract P4-01-05: Circulating ensembles of tumor associated cells for detection of breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Background: Mammographic screening for breast cancer offers the possibility of reducing morbidity and mortality from the disease but has economic and…”
Get full text
Journal Article -
5
Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer
Published in International journal of cancer (15-06-2020)“…Circulating ensembles of tumor‐associated cells (C‐ETACs) which comprise tumor emboli, immune cells and fibroblasts pose well‐recognized risks of thrombosis…”
Get full text
Journal Article -
6
Abstract A49: Viable circulating ensembles of tumor-associated cells persist in pretreated patients with solid organ cancers showing no radiologically detectable disease
Published in Clinical cancer research (01-06-2020)“…Abstract The success of treatment in solid organ cancers is ascertained by radiologic imaging as per standard-of-care protocol, with PET-CT being the modality…”
Get full text
Journal Article -
7
Abstract B15: Circulating tumor cells express tissue specific antigens in multiple cancers
Published in Clinical cancer research (01-06-2020)“…Abstract Definitive diagnosis of solid organ cancers is based on histopathologic analysis of tumor tissue obtained by invasive biopsies. However, invasive…”
Get full text
Journal Article -
8
Abstract B61: Encyclopedic noninvasive liquid biopsies for differential diagnosis in prostate cancer
Published in Clinical cancer research (01-06-2020)“…Abstract Differential diagnosis of prostatic adenocarcinomas is based on histopathologic analysis of tumor tissue obtained by transrectal ultrasound…”
Get full text
Journal Article -
9
Abstract B16: Noninvasive liquid biopsies for guideline-compliant diagnostic assessment in ovarian cancers
Published in Clinical cancer research (01-06-2020)“…Abstract Diagnosis of ovarian adenocarcinomas is based on histopathologic analysis of tumor tissue obtained by invasive biopsies. However, invasive biopsies…”
Get full text
Journal Article -
10
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
Published in Oncotarget (04-08-2022)Get full text
Journal Article -
11
Circulating ensembles of tumor-associated cells in genitourinary cancers
Published in Journal of clinical oncology (20-02-2020)“…Abstract only 718 Background: Detection of genitourinary cancers is based on histopathological analysis of tumor tissue obtained by invasive biopsies following…”
Get full text
Journal Article -
12
Abstract P6-10-11: In vitro chemo interrogation of viable circulating tumor associated cells from breast cancer patients
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Background: Chemoresistance in cancer cells is the underlying reason for treatment failure. Real-time monitoring of chemoresistance and response (CRR)…”
Get full text
Journal Article -
13
PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in gastroesophageal cancers
Published in Journal of clinical oncology (10-02-2020)“…Abstract only 29 Background: Selection of Immune Checkpoint Inhibitor (ICI) therapies in Gastroesophageal cancers are based on IHC based detection of PD-L1…”
Get full text
Journal Article -
14
PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in head and neck cancers
Published in Journal of clinical oncology (10-02-2020)“…Abstract only 36 Background: Selection of Immune Checkpoint Inhibitor (ICI) therapies in Head and Neck cancers are based on IHC based detection of PD-L1…”
Get full text
Journal Article -
15
Concordancy of immunocytochemistry profiling of circulating tumor cells with immunohistochemistry for analysis of therapeutically relevant biomarkers
Published in Journal of clinical oncology (20-05-2021)“…Abstract only 3047 Background: Immunohistochemistry (IHC) profiling of tumor tissue is the present standard for evaluation of therapeutically relevant…”
Get full text
Journal Article -
16
Analytical and clinical validation of the TruCheck platform for diagnostic triaging of symptomatic cases suspected of colorectal cancer
Published in Journal of clinical oncology (20-01-2021)“…Abstract only 24 Background: Trucheck is a non-invasive approach for diagnostic triaging of symptomatic individuals who are suspected of Colorectal Cancer…”
Get full text
Journal Article -
17
Evaluation of circulating tumor cell clusters for pan‐cancer noninvasive diagnostic triaging
Published in Cancer cytopathology (01-03-2021)“…Background Histopathologic examination (HPE) of tumor tissue obtained by invasive biopsy is the standard for cancer diagnosis but is resource‐intensive and has…”
Get full text
Journal Article -
18
Circulating microtumors: A functional hallmark for cancer detection and management
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 3544 Background: There are presently no accepted non-invasive means for detection of cancers in asymptomatic individuals or suspected cases…”
Get full text
Journal Article -
19
Abstract P4-01-17: Viable circulating ensembles of tumor associated cells persist in patients with no radiologically detectable disease after treatment in breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Oncological orthodoxy holds that (metastatic) breast cancer is an incurable disease. Response evaluation in metastatic breast cancer is determined by…”
Get full text
Journal Article -
20
Effect of previous chemotherapy treatments on circulating tumor-associated cells in colorectal cancer
Published in Journal of clinical oncology (01-02-2020)“…Abstract only 194 Background: Resistance to combination regimens of fluorouracil, oxaliplatin and irinotecan are commonly observed in Colorectal cancers (CRC)…”
Get full text
Journal Article